BAIT
ITGA6
CD49f, ITGA6B, VLA-6
integrin, alpha 6
GO Process (17)
GO Function (1)
GO Component (3)
Gene Ontology Biological Process
- amelogenesis [IMP]
- blood coagulation [TAS]
- cell junction assembly [TAS]
- cell-substrate adhesion [IMP]
- cell-substrate junction assembly [TAS]
- digestive tract development [IMP]
- ectodermal cell differentiation [IEP]
- extracellular matrix organization [TAS]
- hemidesmosome assembly [TAS]
- leukocyte migration [TAS]
- nail development [IMP]
- negative regulation of extrinsic apoptotic signaling pathway [IMP]
- positive regulation of apoptotic process [IGI]
- positive regulation of phosphorylation [IMP]
- positive regulation of transcription from RNA polymerase II promoter [IMP]
- renal system development [IMP]
- skin development [IMP]
Gene Ontology Molecular Function
Gene Ontology Cellular Component
Homo sapiens
PREY
MAPK12
ERK-6, ERK3, ERK6, MAPK 12, P38GAMMA, PRKM12, SAPK-3, SAPK3
mitogen-activated protein kinase 12
GO Process (12)
GO Function (3)
GO Component (3)
Gene Ontology Biological Process
- DNA damage induced protein phosphorylation [TAS]
- MAPK cascade [TAS]
- Ras protein signal transduction [TAS]
- cell cycle arrest [TAS]
- muscle cell differentiation [TAS]
- muscle organ development [TAS]
- myoblast differentiation [IDA]
- neurotrophin TRK receptor signaling pathway [TAS]
- peptidyl-serine phosphorylation [IDA, TAS]
- positive regulation of muscle cell differentiation [TAS]
- positive regulation of peptidase activity [NAS]
- signal transduction [TAS]
Gene Ontology Molecular Function
Homo sapiens
Negative Genetic
Mutations/deletions in separate genes, each of which alone causes a minimal phenotype, but when combined in the same cell results in a more severe fitness defect or lethality under a given condition. This term is reserved for high or low throughput studies with scores.
Publication
Synergistic drug combinations for cancer identified in a CRISPR screen for pairwise genetic interactions.
Identification of effective combination therapies is critical to address the emergence of drug-resistant cancers, but direct screening of all possible drug combinations is infeasible. Here we introduce a CRISPR-based double knockout (CDKO) system that improves the efficiency of combinatorial genetic screening using an effective strategy for cloning and sequencing paired single guide RNA (sgRNA) libraries and a robust statistical scoring ... [more]
Nat. Biotechnol. Mar. 20, 2017; 0(); [Pubmed: 28319085]
Quantitative Score
- -2.686 [Confidence Score]
Throughput
- High Throughput
Ontology Terms
- phenotype: growth abnormality (HP:0001507)
Additional Notes
- CRISPR GI screen
- Cell Line:K562 (EFO:0002067)
- Experimental Setup:Timecourse
- GIST: A-phenotypic negative genetic interaction
- Library:Drug Target-CDKO CRISPRn library
- Significance Threshold: q-value<0.05
Curated By
- BioGRID